Myc Physiology in the Pancreatic Beta Cell

胰腺 Beta 细胞中的 Myc 生理学

基本信息

项目摘要

Patients with diabetes would benefit from therapies that increase functional β-cell mass. β-cells naturally adapt to increased metabolic demand and insulin resistance by expanding their functional mass, a process that decreases with aging. We have recently demonstrated a critical role for Myc in adaptive expansion of functional β-cells in young but not old mice. Despite multiple studies describing the effect of Myc overexpression in beta cells, there is a knowledge gap about how this crucial anabolic transcription factor perceives and responds to nutrients and increased insulin demand in its native context. How do nutrients regulate Myc expression in β-cells? How does Myc participate in the regulation of GSIS and mitochondrial function in the β-cell, how does Myc fail to increase adaptive proliferation in aged β-cells or will targeted demethylation of specific Myc binding sites increase β-cell proliferation in metabolically-stressed aged β-cells? These important questions about the physiological role of Myc in the β-cell need to be answered to advance our knowledge and find therapeutic means to treat diabetes. Our overarching hypothesis is that Myc is critical for adaptive β-cell growth and function, and reversing Myc resistance in the T2D-prone or metabolically-stressed aged β-cell can lead to an enhanced adaptive response. We will test our hypothesis by completing the following specific aims: 1) To elucidate how nutrients physiologically upregulate Myc in β-cells and whether Myc upregulation is required for adaptive glucose and β-cell homeostasis in insulin resistance; 2) To determine the physiological role of Myc on insulin secretion and mitochondrial bioenergetics in the β-cell; and, 3) To uncover and modify the mechanisms impairing Myc action in the metabolically-stressed, aged, and T2D β-cells. These studies will deliver unprecedented insight into how Myc is regulated by nutrients, how Myc regulates β-cell function and how to overcome Myc resistance in the metabolically-stressed aged β-cell, which will provide a crucial basic platform for designing and testing novel therapeutic strategies for the treatment of diabetes.
糖尿病患者将受益于增加功能性β细胞质量的疗法。β-细胞通过扩大其功能质量来自然适应增加的代谢需求和胰岛素抵抗,这一过程随着衰老而减少。我们最近已经证明了Myc在年轻而非老年小鼠中功能性β细胞的适应性扩增中的关键作用。尽管有多项研究描述了Myc在β细胞中过表达的影响,但关于这种关键的合成代谢转录因子如何感知和响应营养物质以及在其天然环境中增加胰岛素需求的知识存在差距。营养素如何调节β细胞中Myc的表达?Myc如何参与β细胞中GSIS和线粒体功能的调节,Myc如何不能增加衰老β细胞中的适应性增殖,或者特定Myc结合位点的靶向去甲基化是否会增加代谢应激的衰老β细胞中的β细胞增殖?这些关于Myc在β细胞中的生理作用的重要问题需要得到解答,以提高我们的知识并找到治疗糖尿病的治疗方法。我们的总体假设是Myc对于适应性β细胞生长和功能至关重要,并且逆转T2 D易感或代谢应激的老年β细胞中的Myc抗性可导致增强的适应性反应。我们将通过完成以下具体目标来验证我们的假设:1)阐明营养素如何生理性上调β细胞中Myc,以及Myc上调是否是胰岛素抵抗中适应性葡萄糖和β细胞稳态所必需的; 2)确定Myc对β细胞中胰岛素分泌和线粒体生物能量学的生理作用;(3)揭示和改变代谢应激、衰老和T2 D β细胞中Myc作用受损的机制。这些研究将提供前所未有的洞察Myc如何受营养素调节,Myc如何调节β细胞功能以及如何克服代谢应激的老年β细胞中的Myc抗性,这将为设计和测试治疗糖尿病的新治疗策略提供关键的基础平台。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adolfo Garcia-Ocana其他文献

Adolfo Garcia-Ocana的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adolfo Garcia-Ocana', 18)}}的其他基金

Myc Physiology in the Pancreatic Beta Cell
胰腺 Beta 细胞中的 Myc 生理学
  • 批准号:
    10224945
  • 财政年份:
    2020
  • 资助金额:
    $ 50.25万
  • 项目类别:
Myc Physiology in the Pancreatic Beta Cell
胰腺 Beta 细胞中的 Myc 生理学
  • 批准号:
    10399579
  • 财政年份:
    2020
  • 资助金额:
    $ 50.25万
  • 项目类别:
Dextran Sulfate, Beta Cell Preservation and Immune Regulation in Type 1 Diabetes
硫酸葡聚糖、β 细胞保存和 1 型糖尿病的免疫调节
  • 批准号:
    9289335
  • 财政年份:
    2017
  • 资助金额:
    $ 50.25万
  • 项目类别:
Protein Kinase C (PKC) Zeta and the Pancreatic Beta Cell
蛋白激酶 C (PKC) Zeta 和胰腺 Beta 细胞
  • 批准号:
    7992533
  • 财政年份:
    2010
  • 资助金额:
    $ 50.25万
  • 项目类别:
Protein Kinase C (PKC) Zeta and the Pancreatic Beta Cell
蛋白激酶 C (PKC) Zeta 和胰腺 Beta 细胞
  • 批准号:
    8080879
  • 财政年份:
    2008
  • 资助金额:
    $ 50.25万
  • 项目类别:
Protein Kinase C (PKC) Zeta and the Pancreatic Beta Cell
蛋白激酶 C (PKC) Zeta 和胰腺 Beta 细胞
  • 批准号:
    8577347
  • 财政年份:
    2008
  • 资助金额:
    $ 50.25万
  • 项目类别:
Protein Kinase C (PKC) Zeta and the Pancreatic Beta Cell
蛋白激酶 C (PKC) Zeta 和胰腺 Beta 细胞
  • 批准号:
    7674801
  • 财政年份:
    2008
  • 资助金额:
    $ 50.25万
  • 项目类别:
Protein Kinase B/Akt in the human islet
人胰岛中的蛋白激酶 B/Akt
  • 批准号:
    6948172
  • 财政年份:
    2004
  • 资助金额:
    $ 50.25万
  • 项目类别:
Protein Kinase B/Akt in the human islet
人胰岛中的蛋白激酶 B/Akt
  • 批准号:
    6830924
  • 财政年份:
    2004
  • 资助金额:
    $ 50.25万
  • 项目类别:
Hepatocyte Growth Factor and The Pancreatic Beta Cell
肝细胞生长因子和胰腺β细胞
  • 批准号:
    8472477
  • 财政年份:
    2004
  • 资助金额:
    $ 50.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了